Steven Moss

The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK.

BVF, Inc. manages engages in investment business and manages biotech focused hedge funds. The firm manages Biotechnology Value Fund LP and Biotechnology Value Fund II LP. The company was founded by Mark Nathan Lampert on September 14, 1993 and is headquartered in San Francisco, CA.

Part of Schroders Plc, Schroder Ventures Holdings Plc is a private equity firm.

Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

Incyte Pharmaceuticals, Inc. engages in the provision of biopharmaceutical services. The company was founded in April, 1991 is headquartered in Palo Alto, CA.

Part of Incyte Corp., Hexagen Plc develops technology for the discovery of single nucleotide polymorphisms. The British company was founded by Andrew Peter Sandham, Stephen William Bunting. Hexagen was acquired by Incyte Corp. on September 22, 1998 for $25.99 million.

Part of Dassault Systèmes SA, Synomics Ltd. implements software primarily for the biological and pharmaceutical industry. The company is based in Cambridge, UK. Peter Juul Kristensen has been the CEO of the British company since 2020. Synomics was acquired by BIOVIA, Inc., part of Dassault Systèmes SA from April 30, 2014 on June 29, 2001 for $3.50 million.

Part of JPMorgan Chase & Co., JPMorgan Partners Europe is a private equity group. The company is based in London, UK.

General Electric Canada Co. manufactures and markets products for the generation and distribution of electricity. It offers aircraft engines, power generation, water processing, and security technology to medical imaging, business & consumer financing, and media content. The company was founded by Thomas Edison in 1892 and is headquartered in Mississauga, Canada.

Biotechnology & Biological Sciences Research Council operates a funding agency for academic research and training. It funds bioscience, people and research infrastructure that helps to tackle major challenges such as the impact of climate change, a healthier old age, and sustainable food production, land use and energy production. The company is headquartered in Swindon, the United Kingdom.

Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge.

The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012.

Aquilo Capital Management LLC (Aquilo) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. Aquilo was founded in 2010 to manage investment funds and separately managed accounts for individual clients.

Linaro Ltd. is a collaboration platform for the Arm partnership. The non-profit company is based in Cambridge, UK. The British company provides a space where members can collaborate on Arm Open Source Software and solutions. The company was founded in 2010. Gong Li has been the CEO of the company since 2019.

Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom.

BVF Partners OS Ltd. provides real estate services.

Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom.

Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom.

OMass Therapeutics Ltd. develops native mass spectrometry platform The company was founded by Dame Carol Robinson and is headquartered in Oxford, the United Kingdom.

Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom.

Qkine Ltd. provides growth factors and bioactive proteins for use in stem cell science and regenerative medicine applications. Its products include Activin A and FGF2. The firm specializes in protein purification, organoids, cytokines, and protein-engineering. The company was founded by Marko Hyvonen and Catherine Elton in 2016 and is headquartered in Cambridge, the United Kingdom.

Polyprox Therapeutics Ltd. operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases. The company was founded by Laura S. Itzhaki in 2018 and is headquartered in Cambridge, the United Kingdom.

Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom.

Spirea Ltd. operates as a healthcare technology company. It develops smart polymer platform for the controlled delivery of drug combinations to maximise the clinical impact of medicines. The company was founded by Myriam Ouberai and is headquartered in arrogate, the United Kingdom.

Resolution Therapeutics Ltd. operates as a macrophage cell therapy company. The company was founded on December 14, 2017 and is headquartered in London, the United Kingdom.

SDS Therapeutics Ltd. is a British biotechnology company founded in 2020 that provides research and development services. The company is based in Cambridge, UK.